Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest reportWe have teamed up with the Dutch university Tu Delft to develop new generations of nuclear scientists.
Read more Urenco partners with leading nuclear university to invest in talentGetting closer to achieving our near-term emissions target by 2030
Read more Urenco’s Netherlands site is to be powered with low-carbon electricity from a nuclear power stationRafael Grossi had a tour of our enrichment plant SP5 and our production facility for medical isotopes.
Read more IAEA director general visits Urenco’s Netherlands siteProject at our Almelo site in the Netherlands will help us deliver and strengthen the fuel supply chain.
Read more Energy security boost as Urenco breaks ground on site extensionJointly enhance the influx of employees needed for nuclear ambitions
Read more Cooperation between vocational schools and nuclear sector to develop Dutch nuclear curriculumAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries